Global Hydrogel-based Drug Delivery System Market Insights Forecasts to 2033

• The Global Hydrogel-based Drug Delivery System Market Size was Valued at USD 7.39 Billion in 2023
• The Market Size is Growing at a CAGR of 6.67% from 2023 to 2033
• The Worldwide Hydrogel-based Drug Delivery System Market Size is Expected to Reach USD 14.10 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Hydrogel-based Drug Delivery System Market Size is Anticipated to Exceed USD 14.10 Billion by 2033, Growing at a CAGR of 6.67% from 2023 to 2033. Physicians can improve the biocompatibility of products by utilizing the hydrogel-based drug delivery market analysis, which indicates that the market is experiencing these types of trends.     

Market Overview

Hydrogels are a particularly attractive kind of drug delivery system that is applied in many medical specialties, such as immunology, cardiology, oncology, wound healing, and pain relief. A cross-linked network of polymers and an immense quantity of water-structure hydrogels. Different therapeutic agents, such as cells, macromolecular capsules, and small-molecule capsules, can be released from hydrogels with temporal and spatial control. Hydrogels can cover up the sour taste and odor of medications. Hydrogels can be used in a variety of ways, including injectable, oral, nasal, buccal, rectal, vaginal, and ocular. For Instance, in March 2022, Johnson & Johnson Vision Care, Inc. announced that ACUVUE® TheravisionTM with Ketotifen has received FDA approval. A contact lens that contains ketotifen. The amount of ketotifen in each lens is 19 mcg. The market is driven by this increased need for sophisticated drug delivery systems. The growing use of hydrogel-based drug delivery systems to treat a range of illnesses, including metabolic syndrome, is anticipated to drives the growth in hydrogel-based drug delivery system market.    

Challenges

There are several technical challenges with the drug delivery method. System dependability can be affected by doubts about formulation stability, medication loading effectiveness, and release kinetics. Consequently, this factor hinders the growth of the global hydrogel-based drug delivery market.

Report Coverage

This research report categorizes the hydrogel-based drug delivery system market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the hydrogel-based drug delivery system market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the hydrogel-based drug delivery system market.

Driving Factors

Proteins and nucleic acids can be effectively encapsulated by hydrogels due to their unique features, which is driving additional developments in hydrogel-based drug delivery systems market. Due to characteristics like self-application and ease of manufacture, hydrogels are the ideal drug carrier. Patients need for customized and comfortable treatments for their medical conditions driving the growth in the hydrogel-based drug delivery systems market. Hydrogel drug delivery system-based new drug are being approved for sale, which can help drive the hydrogel-based drug delivery system market.  

Restraining Factors

The compatibility issues with a limited range of medications, hydrogel's high rate, and its low mechanical power are the problems that are expected to restrict the growth in the hydrogel-based drug delivery system market.

Market Segmentation

The hydrogel-based drug delivery system market share is classified into polymer origin and route.  

• The natural segment is estimated to hold the largest market revenue share through the projected period.   

Based on the polymer origin, the hydrogel-based drug delivery system market is classified into natural, synthetic, and hybrid. Among these, the natural segment is estimated to hold the largest market revenue share through the projected period. Proteins including collagen, lysosomes, and gelatin as well as polysaccharides including chitosan, hyaluronic acid, and alginate are used to help produce natural hydrogels.      

• The ocular segment is anticipated to hold the largest market share through the forecast period.

Based on the route, the hydrogel-based drug delivery system market is divided into subcutaneous, ocular, oral cavity, and others. Among these, the ocular segment is anticipated to hold the largest market share through the forecast period. The hydrogel films are used to make the majority of hard and contact lenses, hydrogels are typically used in ocular drug delivery applications.    

Regional Segment Analysis of the Hydrogel-based Drug Delivery System Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the hydrogel-based drug delivery system market over the predicted timeframe.

North America is anticipated to hold the largest share of the hydrogel-based drug delivery system market over the predicted timeframe. The primary factors expected to drive the market in North America are the availability of effective reimbursement that covers the cost of modern therapies, the domestic presence of hydrogel suppliers, and frequent product introductions. The main causes of favorable reimbursement scenarios that cover the price of contemporary treatments are the existence of regional hydrogel suppliers, the introduction of innovative products by significant regional businesses, and other aspects.

Asia Pacific is expected to grow at the fastest CAGR growth of the hydrogel-based drug delivery system market during the forecast period. The Asia Pacific market for hydrogel-based drug delivery systems is driven by a sizable target population, greater healthcare accessibility, a growing desire for better medical treatment across a range of therapeutic areas, and a growing focus on reducing healthcare costs. Due to growing foreign investments in China's pharmaceutical market in the quest for innovative drug delivery and diagnostic technologies, the country has a growing hydrogel-based drug delivery market.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the hydrogel-based drug delivery system market along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• GALDERMA
• Blairex Laboratories, Inc
• Johnson & Johnson
• Bausch + Lomb.
• Medtronic
• Ocular Therapeutix, Inc.
• Ferring B.V.
• Endo, Inc.
• Tolmar Inc
• Others  

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In June 2023, infuse multifocal silicone hydrogel contact lenses were launched in the US market by Bausch + Lomb. Using silicone hydrogel (SiHy) helps customers with long-term usability by reducing the exchanges between wettability and oxygen permeability.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the hydrogel-based drug delivery system market based on the below-mentioned segments: 

Global Hydrogel-based Drug Delivery System Market, By Polymer Origin

• Natural
• Synthetic
• Hybrid

Global Hydrogel-based Drug Delivery System Market, By Route

• Subcutaneous
• Ocular
• Oral Cavity
• Others

Global Hydrogel-based Drug Delivery System Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa